EMBC - NASDAQ

Embecta Corp.

EMBC·NASDAQ

$3.32

-2.8%

HealthcareDrug Manufacturers - Specialty & Generic

Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety devices, as well as digital applications to assist people with managing their diabetes. The company primarily sells its products to wholesalers and distributors in the United States and internationally. Embecta Corp. was founded in 1924 and is based in Parsippany, New Jersey. Embecta Corp.(NasdaqGS:EMBC) operates independently of Becton, Dickinson and Company as of April 1, 2022.

Statements Value Model

At a Glance

Live Snapshot

Market Cap$196.97M

EPS1.6400

P/E Ratio2.02

Earnings Date08/06/2026

embc

Stock Based Compensation

Last Annual Value

31.60M

3-Year CAGR

19%

5-Year CAGR

20%

10-Year CAGR

10%

Adjust for Inflation

Embecta Corp. Competitors Analysis of Stock Based Compensation

EMBC · NASDAQ

Company	Stock Based Compensation	CAGR 3Y	CAGR 5Y	CAGR 10Y
Embecta Corp. NASDAQ:EMBC	31.60M	13.7%	19.8%	N/A
Maravai LifeSciences Holdings, Inc. NASDAQ:MRVI	0.00	N/A	N/A	N/A
CareDx, Inc NASDAQ:CDNA	34.86M	-10.8%	-0.7%	33.1%
Prime Medicine, Inc. NASDAQ:PRME	29.27M	28.1%	75.7%	N/A
Personalis, Inc. NASDAQ:PSNL	9.43M	-12.5%	-8.1%	N/A
Aquestive Therapeutics, Inc. NASDAQ:AQST	7.62M	41.5%	2.3%	N/A
SIGA Technologies, Inc. NASDAQ:SIGA	3.64M	21.0%	23.5%	16.7%
Evolent Health, Inc. NYSE:EVH	39.74M	-0.6%	18.9%	5.9%
Emergent BioSolutions Inc. NYSE:EBS	16.20M	-11.2%	-17.5%	-1.3%
Myriad Genetics, Inc. NASDAQ:MYGN	0.00	N/A	N/A	N/A
Vir Biotechnology, Inc. NASDAQ:VIR	49.07M	N/A	-10.1%	N/A

Embecta Corp. Fair Value Envelope

EMBC · NASDAQ

Our analysis suggests that EMBC has a fair value of HIDDEN per share in the Base Case projection. With shares currently trading at $3.32, this represents a potential HIDDEN relative to our calculated worth for Embecta Corp..

HIDDEN

Intrinsic Value

Current Price: $3.32

Related Guides

Blog Categories

Continue your EMBC research with focused valuation guides.

Fundamentals

Decode statement quality and operating durability.

Accounting

Interpret line items with cleaner analytical framing.

Forecasting

Translate historical performance into forward scenarios.

Reference

Use practical frameworks for statement-led valuation.

Research Paths

Pick your next lens

Snapshot

Start with context, operating signals, and key market metrics.

Value Model

Stress test fair value across bear, base, and bull assumptions.

Statements

Validate revenue quality, margins, and balance sheet durability.

Earnings Call

Read management commentary and compare it with reported outcomes.

Dividends

Check payout sustainability and long-term distribution behavior.

Analyst Expectations

Review consensus spread and where estimate risk is concentrated.